 Here are 5 potential future research ideas based on the paper:

1. Further optimize and develop compound 256 as a lead TRAF6 inhibitor through medicinal chemistry approaches like structure-activity relationship studies. Test the in vitro and in vivo efficacy of the optimized compound 256 analogs.

2. Explore the binding interactions and inhibition efficacy of compound 256 on full-length TRAF6 through biochemical assays and structural studies. 

3. Investigate the effects of compound 256 on downstream signaling pathways like NF-kB and MAPKs and its therapeutic potential in cancer or inflammation models.

4. Design and synthesize new derivatives based on other scaffolds that can mimic compound 256 interactions and test their TRAF6 inhibition.

5. Elucidate the binding mode and explore structure-based drug design approaches to develop allosteric inhibitors that bind to regions outside the zinc fingers of TRAF6.